The Standardized Management of Hypertension in Rural Shaanxi

NACompletedINTERVENTIONAL
Enrollment

1,210

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

February 28, 2019

Conditions
Hypertension
Interventions
DRUG

Hydrochlorothiazide, Captopril, Nitrendipine, Aspirin

The participants were grouped into a control group and a TDP group. Hypertension of patients in the control group was managed with the original protocol by doctors in village clinics. Patients in the TDP group were supplied with the TDP treatment, for whom different levels of oral administration plans to patients without drugs treatment in original protocol were: G 0 and G I, nifedipine (20mg, bid) or captopril (25mg, tid), hydrochlorothiazide (12.5mg, bid) for patients who couldn't tolerate previous drugs; G II, nifedipine (20mg, bid) plus hydrochlorothiazide (12.5mg, bid), or captopril (25mg, tid) plus hydrochlorothiazide (12.5mg, bid ), triple therapy for patients whose blood pressure did not reach target BP; G III, three drugs combination. Patients with drugs treatments in the original protocol were changed to be treated with the above antihypertension medications which were uniformly supplied by the government.

Trial Locations (1)

Unknown

the first affiliated hospital of Xi'an Jiaotong university, Xi'an

All Listed Sponsors
lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER

NCT04371874 - The Standardized Management of Hypertension in Rural Shaanxi | Biotech Hunter | Biotech Hunter